GEVIMIS - Trademark Details
Status: 401 - Ir Cancelled - No Transformation Filed
Serial Number
79184643
Registration Number
5029385
Word Mark
GEVIMIS
Status
401 - Ir Cancelled - No Transformation Filed
Status Date
2021-01-15
Filing Date
2016-01-22
Registration Number
5029385
Registration Date
2016-08-30
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2016-06-14
Law Office Assigned Location Code
L70
Employee Name
DUBOIS, MICHELLE E
Statements
Certificate of Correction for Registration
In the statement, lines 4 through 21, " Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; " should be deleted. In the statement, " lines 22 through 24, " ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma " should be inserted.
Goods and Services
[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] pharmaceutical products for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ]
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
H - Section 70 - Cancelled
Class Status Date
2019-10-17
Primary Code
005
Correspondences
Name
Novartis Pharma AG,; Trademark Departmen
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1292345
International Registration Date
2016-01-22
International Publication Date
2016-03-17
International Renewal Date
2026-01-22
Auto Protection Date
2017-09-17
International Status
101 - IR cancelled (Dead as a result of Total Cancellation)
International Status Date
2020-10-08
Priority Claimed In
True
Priority Claimed Date
2016-01-13
First Refusal In
False
Trademark Events
Event Date | Event Description |
2016-03-17 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2016-03-19 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
2016-03-21 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-03-25 | APPLICATION FILING RECEIPT MAILED |
2016-05-02 | ASSIGNED TO EXAMINER |
2016-05-04 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-05-25 | NOTICE OF PUBLICATION |
2016-06-01 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2016-06-01 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2016-06-14 | PUBLISHED FOR OPPOSITION |
2016-07-28 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2016-08-30 | REGISTERED-PRINCIPAL REGISTER |
2016-09-29 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
2016-10-03 | FINAL DISPOSITION PROCESSED |
2016-10-03 | FINAL DISPOSITION NOTICE SENT TO IB |
2016-10-21 | NOTIFICATION PROCESSED BY IB |
2017-04-07 | LIMITATION OF GOODS RECEIVED FROM IB |
2017-04-26 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2017-04-26 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
2017-04-26 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
2017-12-26 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
2018-01-11 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
2019-11-01 | DEATH OF INTERNATIONAL REGISTRATION |
2019-11-01 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
2020-10-24 | DEATH OF INTERNATIONAL REGISTRATION |
2020-10-25 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
2021-05-23 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |